Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ELN Foundation is a non-profit organization that coordinates the European LeukemiaNet, a major international research network focused on leukemia. It integrates over 100 institutions across 33 countries to harmonize clinical trials, diagnostics, and treatment standards for hematological malignancies. The foundation is widely recognized for publishing the ELN recommendations, which serve as the global gold standard for the management of Acute Myeloid Leukemia (AML) and Chronic Myeloid Leukemia (CML). Through its infrastructure, it facilitates large-scale registries and collaborative studies that bridge the gap between laboratory research and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ELN Foundation.